A Study of Sodium Carboxymethylcellulose for Post Cataract Surgery Dry Eye Symptoms
NCT02028754 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 180
Last updated 2014-04-23
Summary
This study will evaluate the effect of sodium carboxymethylcellulose eye drops in the treatment of dry eye after cataract surgery.
Conditions
- Dry Eye Syndromes
- Cataract
Interventions
- DRUG
-
Sodium Carboxymethylcellulose
Sodium carboxymethylcellulose (Refresh Liquigel®) 1 drop in the study eye 4 times a day for 30 days post-cataract surgery.
- DRUG
-
Levofloxacin
Levofloxacin 1 drop in the study eye 3 times a day for 7 days post-cataract surgery.
- DRUG
-
Prednisolone
Prednisolone 1 drop in the study eye 4 times a day for the 1st week post surgery, 3 times a day for the 2nd week post surgery, 2 times a day for the 3rd week post surgery, and 1 time a day for the 4th week post surgery.
Sponsors & Collaborators
-
Allergan
lead INDUSTRY
Principal Investigators
-
Medical Director · Allergan
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 60 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-07-31
- Primary Completion
- 2013-05-31
- Completion
- 2013-05-31
Countries
- China
Study Locations
More Related Trials
-
Use of Prophylactic Lubricating Drops After Cataract Surgery
NCT04131335 ·Status: UNKNOWN ·Phase: NA
-
Levofloxacin Ocular Implant for Ocular Surgery
NCT04682288 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Intraoperative Dexamethasone on Post-op Dry Eye
NCT04184999 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Efficacy and Safety of Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis.
NCT02770729 ·Status: TERMINATED ·Phase: PHASE3
-
Evaluation Of Aqueous Humor Of Levofloxacin-Dexamethasone Eye Drops And Of Its Components In Patients Undergoing Cataract Surgery
NCT03740659 ·Status: COMPLETED ·Phase: PHASE2
-
Metabolomic Profile in Dry Eye Syndrome Patients.
NCT05433428 ·Status: UNKNOWN ·Phase: PHASE4
-
Effectiveness of Periocular Drug Injection in CATaract Surgery
NCT05158699 ·Status: TERMINATED ·Phase: PHASE3
-
A Clinical Study to Assess the Efficacy and Safety of Dexamethasone Suspension for Cataract Surgery
NCT03687931 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Dropless vs. Standard Drops Contralateral Eye Study
NCT02515045 ·Status: COMPLETED ·Phase: PHASE4
-
Lidocaine Usage for Pupil Dilatation (Mydriasis)
NCT01170130 ·Status: COMPLETED ·Phase: NA
-
Eye Drop Use in Glaucoma Patients Through Patient Surveys and Video Observations
NCT00522600 ·Status: COMPLETED
-
Role of Postoperative Lubrication in Cataract Surgery
NCT06555224 ·Status: COMPLETED ·Phase: PHASE4
-
To Compare the Safety and Efficacy of Intracameral Levofloxacin and Intracameral Cefazolin in Reducing Rates of Endophthalmitis Following Cataract Surgery.
NCT06710977 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery
NCT05626478 ·Status: COMPLETED ·Phase: PHASE4
-
Topical Proparacaine Eye Drops to Improve the Experience of Patients Undergoing Intravitreal Injections
NCT02951351 ·Status: COMPLETED ·Phase: NA
-
A Trial Evaluating Patient Preference of Dropless vs Drops Post Cataract Surgery
NCT04205916 ·Status: RECRUITING ·Phase: PHASE4
-
The Effect of Ophthalmic Solutions on Contact Lenses Used After Surgery for Congenital Cataract Investigated in Vivo
NCT03125785 ·Status: UNKNOWN
-
Protection of Corneal Epithelium Using Chitosan-N-acetylcysteine Eye Drops During and/or After Cataract Surgery
NCT05064189 ·Status: COMPLETED ·Phase: NA
-
Postoperative Safety Outcomes of Intraoperative Intracameral Preservative-Free Moxifloxacin Versus Levofloxacin
NCT04403334 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Necessity of Anti-inflammatory Drops After Laser Peripheral Iridotomy
NCT02955641 ·Status: UNKNOWN ·Phase: NA
-
Ketorolac Plus Tobramycin/Dexamethasone Versus Tobramycin/Dexamethasone After Uneventful Phacoemulsification Surgery
NCT01103401 ·Status: COMPLETED ·Phase: NA
-
RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery - GUARD
NCT02128113 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy, Tolerability, and Comfort of 0.3% Hypromellose Eyedrops in Patients Undergoing LASIK Surgery
NCT00909324 ·Status: COMPLETED ·Phase: PHASE4
-
Cross-Over Evaluation of Two Lubricating Eye Drops
NCT00493662 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy Mydrane ® for Cataract Surgery in Patients With Concomitant Primary Open Angle Glaucoma.
NCT05925894 ·Status: COMPLETED ·Phase: NA